Iron Deficiency Anemia
Iron deficiency (ID) and iron deficiency anemia (IDA) are prevalent conditions all over the world. The groups at highest risk are children, pre-menopausal women and socially disadvantaged people. Diagnose of ID using a full blood examination and iron studies can be difficulted by concomitant inflamm...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
IntechOpen
2019
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_130707 | ||
005 | 20231201 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20231201s2019 xx |||||o ||| 0|eng d | ||
020 | |a intechopen.73922 | ||
020 | |a 9781789854442 | ||
020 | |a 9781789854435 | ||
020 | |a 9781838806422 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.5772/intechopen.73922 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a MJF |2 bicssc | |
100 | 1 | |a Rodrigo, Luis |4 edt | |
700 | 1 | |a Rodrigo, Luis |4 oth | |
245 | 1 | 0 | |a Iron Deficiency Anemia |
260 | |b IntechOpen |c 2019 | ||
300 | |a 1 electronic resource (124 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Iron deficiency (ID) and iron deficiency anemia (IDA) are prevalent conditions all over the world. The groups at highest risk are children, pre-menopausal women and socially disadvantaged people. Diagnose of ID using a full blood examination and iron studies can be difficulted by concomitant inflammation. Management of ID involves identification and treatment of its cause, as well as effective iron replacement. Patients who fail to respond to iron replacement will performed an endoscopy to exclude internal bleeding. Both enteral and parenteral iron are effective at replacing iron. For adult patients, we recommend trialling daily oral iron (30-100 mg of iron) as the first-line therapy. Patients who fail to respond to oral iron replacement can be safely managed with intravenous iron. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/3.0/ |2 cc |4 https://creativecommons.org/licenses/by/3.0/ | ||
546 | |a English | ||
650 | 7 | |a Haematology |2 bicssc | |
653 | |a heart failure, cadmium, lead, heart disease, hepcidin, hemoglobin | ||
856 | 4 | 0 | |a www.oapen.org |u https://mts.intechopen.com/storage/books/7125/authors_book/authors_book.pdf |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/130707 |7 0 |z DOAB: description of the publication |